4//SEC Filing
Davis Todd C 4
Accession 0001753926-25-001105
CIK 0001919246other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 9:43 PM ET
Size
8.3 KB
Accession
0001753926-25-001105
Insider Transaction Report
Form 4
Davis Todd C
Director
Transactions
- Award
Stock Option
2025-07-02+58,230→ 58,230 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (58,230 underlying) - Award
Restricted Stock Units
2025-07-02+19,108→ 36,969 totalExercise: $13.50From: 2026-07-02Exp: 2035-07-02→ Common Stock (19,108 underlying)
Footnotes (3)
- [F1]On July 2, 2025, the Reporting Person was granted restricted stock units to purchase 19,108 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis over a period of three (3) years.
- [F2]On July 2, 2025, the Reporting Person was granted stock options to purchase 58,230 shares of common stock at an exercise price of $13.50 per share, which shall vest on a quarterly basis over a period of three (3) years.
- [F3]The numbers reported herein have been adjusted to reflect the 1-for-10 reverse stock split effected by the Issuer on July 1, 2025.
Documents
Issuer
Pelthos Therapeutics Inc.
CIK 0001919246
Entity typeother
Related Parties
1- filerCIK 0001392029
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 9:43 PM ET
- Size
- 8.3 KB